Loading company details...
Latest Form 4 (Nov 2, 2026): Paul A. Keel (Chairman and CEO): Tax Withholding of 54,197 shares, $1.27M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 2, 2026 | Paul A. Keel, Chairman and CEO | Tax Withholding | 54,197 | $1.27M |
| Aug 27, 2026 | Veronica Acurio, President, Orthodontics | Tax Withholding | 7,710 | $211.8K |
| Aug 27, 2026 | Robert Befidi, President, Diagnostics | Tax Withholding | 5,147 | $141.4K |
| Aug 27, 2026 | Eric D. Hammes, Chief Financial Officer | Tax Withholding | 10,885 | $299.0K |
| Aug 27, 2026 | Stefan Nilsson, President, Nobel Biocare | Tax Withholding | 804 | $22.1K |
| Aug 24, 2026 | Mischa Reis, SVP, Strategy & Bus. Dev. | Sale | 8,000 | $220.0K |
| Aug 20, 2026 | Paul A. Keel, Chief Executive Officer | Grant/Award | 179,730 | n/a |
| Aug 20, 2026 | Eric D. Hammes, Chief Financial Officer | Grant/Award | 47,970 | n/a |
| May 27, 2026 | Paul A. Keel, Chief Executive Officer | Tax Withholding | 12,811 | $300.2K |
| May 21, 2026 | Wendy Carruthers | Grant/Award | 9,330 | n/a |